vs
Apellis Pharmaceuticals, Inc.（APLS）与Kodiak Gas Services, Inc.（KGS）财务数据对比。点击上方公司名可切换其他公司
Kodiak Gas Services, Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.7倍（$332.9M vs $199.9M），Kodiak Gas Services, Inc.净利率更高（7.4% vs -29.5%，领先36.9%），Kodiak Gas Services, Inc.同比增速更快（7.5% vs -5.9%），Kodiak Gas Services, Inc.自由现金流更多（$142.0M vs $-14.3M），过去两年Kodiak Gas Services, Inc.的营收复合增速更高（24.3% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Kodiak Gas Services是北美知名的天然气压缩服务供应商，主要服务油气行业上下游客户，提供定制化压缩设备、运维及运营支持，帮助客户优化陆上天然气收集、处理与运输全流程的运营效率。
APLS vs KGS — 直观对比
营收规模更大
KGS
是对方的1.7倍
$199.9M
营收增速更快
KGS
高出13.5%
-5.9%
净利率更高
KGS
高出36.9%
-29.5%
自由现金流更多
KGS
多$156.3M
$-14.3M
两年增速更快
KGS
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $332.9M |
| 净利润 | $-59.0M | $24.6M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 26.1% |
| 净利率 | -29.5% | 7.4% |
| 营收同比 | -5.9% | 7.5% |
| 净利润同比 | -62.2% | 29.0% |
| 每股收益（稀释后） | $-0.40 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSKGS
| Q4 25 | $199.9M | $332.9M | ||
| Q3 25 | $458.6M | $322.7M | ||
| Q2 25 | $178.5M | $322.8M | ||
| Q1 25 | $166.8M | $329.6M | ||
| Q4 24 | $212.5M | $309.5M | ||
| Q3 24 | $196.8M | $324.6M | ||
| Q2 24 | $199.7M | $309.7M | ||
| Q1 24 | $172.3M | $215.5M |
净利润APLSKGS
| Q4 25 | $-59.0M | $24.6M | ||
| Q3 25 | $215.7M | $-14.0M | ||
| Q2 25 | $-42.2M | $39.5M | ||
| Q1 25 | $-92.2M | $30.4M | ||
| Q4 24 | $-36.4M | $19.1M | ||
| Q3 24 | $-57.4M | $-5.6M | ||
| Q2 24 | $-37.7M | $6.2M | ||
| Q1 24 | $-66.4M | $30.2M |
毛利率APLSKGS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 37.5% | ||
| Q2 24 | — | 36.5% | ||
| Q1 24 | — | 39.4% |
营业利润率APLSKGS
| Q4 25 | -25.6% | 26.1% | ||
| Q3 25 | 48.7% | 19.9% | ||
| Q2 25 | -18.6% | 30.9% | ||
| Q1 25 | -50.0% | 27.1% | ||
| Q4 24 | -12.3% | 22.3% | ||
| Q3 24 | -24.0% | 20.4% | ||
| Q2 24 | -14.7% | 17.5% | ||
| Q1 24 | -36.0% | 27.9% |
净利率APLSKGS
| Q4 25 | -29.5% | 7.4% | ||
| Q3 25 | 47.0% | -4.3% | ||
| Q2 25 | -23.6% | 12.2% | ||
| Q1 25 | -55.3% | 9.2% | ||
| Q4 24 | -17.1% | 6.2% | ||
| Q3 24 | -29.2% | -1.7% | ||
| Q2 24 | -18.9% | 2.0% | ||
| Q1 24 | -38.5% | 14.0% |
每股收益（稀释后）APLSKGS
| Q4 25 | $-0.40 | $0.30 | ||
| Q3 25 | $1.67 | $-0.17 | ||
| Q2 25 | $-0.33 | $0.43 | ||
| Q1 25 | $-0.74 | $0.33 | ||
| Q4 24 | $-0.30 | $0.18 | ||
| Q3 24 | $-0.46 | $-0.07 | ||
| Q2 24 | $-0.30 | $0.06 | ||
| Q1 24 | $-0.54 | $0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $3.2M |
| 总债务越低越好 | — | $2.6B |
| 股东权益账面价值 | $370.1M | $1.2B |
| 总资产 | $1.1B | $4.3B |
| 负债/权益比越低杠杆越低 | — | 2.12× |
8季度趋势，按日历期对齐
现金及短期投资APLSKGS
| Q4 25 | $466.2M | $3.2M | ||
| Q3 25 | $479.2M | $724.0K | ||
| Q2 25 | $370.0M | $5.4M | ||
| Q1 25 | $358.4M | $1.9M | ||
| Q4 24 | $411.3M | $4.8M | ||
| Q3 24 | $396.9M | $7.4M | ||
| Q2 24 | $360.1M | $3.9M | ||
| Q1 24 | $325.9M | $9.3M |
总债务APLSKGS
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | $93.1M | — |
股东权益APLSKGS
| Q4 25 | $370.1M | $1.2B | ||
| Q3 25 | $401.2M | $1.3B | ||
| Q2 25 | $156.3M | $1.3B | ||
| Q1 25 | $164.2M | $1.4B | ||
| Q4 24 | $228.5M | $1.4B | ||
| Q3 24 | $237.1M | $1.4B | ||
| Q2 24 | $264.3M | $1.5B | ||
| Q1 24 | $266.7M | $1.1B |
总资产APLSKGS
| Q4 25 | $1.1B | $4.3B | ||
| Q3 25 | $1.1B | $4.4B | ||
| Q2 25 | $821.4M | $4.4B | ||
| Q1 25 | $807.3M | $4.4B | ||
| Q4 24 | $885.1M | $4.4B | ||
| Q3 24 | $901.9M | $4.5B | ||
| Q2 24 | $904.5M | $4.4B | ||
| Q1 24 | $831.9M | $3.3B |
负债/权益比APLSKGS
| Q4 25 | — | 2.12× | ||
| Q3 25 | — | 2.08× | ||
| Q2 25 | — | 1.89× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 1.88× | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | — | 1.71× | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $194.9M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $142.0M |
| 自由现金流率自由现金流/营收 | -7.1% | 42.7% |
| 资本支出强度资本支出/营收 | 0.1% | 15.9% |
| 现金转化率经营现金流/净利润 | — | 7.91× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $284.3M |
8季度趋势，按日历期对齐
经营现金流APLSKGS
| Q4 25 | $-14.2M | $194.9M | ||
| Q3 25 | $108.5M | $113.4M | ||
| Q2 25 | $4.4M | $177.2M | ||
| Q1 25 | $-53.4M | $114.3M | ||
| Q4 24 | $19.4M | $118.5M | ||
| Q3 24 | $34.1M | $36.9M | ||
| Q2 24 | $-8.3M | $121.1M | ||
| Q1 24 | $-133.0M | $51.5M |
自由现金流APLSKGS
| Q4 25 | $-14.3M | $142.0M | ||
| Q3 25 | $108.3M | $10.9M | ||
| Q2 25 | $4.4M | $94.6M | ||
| Q1 25 | $-53.4M | $36.8M | ||
| Q4 24 | $19.3M | $45.2M | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | $-8.4M | $4.0M | ||
| Q1 24 | $-133.3M | $-8.6M |
自由现金流率APLSKGS
| Q4 25 | -7.1% | 42.7% | ||
| Q3 25 | 23.6% | 3.4% | ||
| Q2 25 | 2.5% | 29.3% | ||
| Q1 25 | -32.0% | 11.2% | ||
| Q4 24 | 9.1% | 14.6% | ||
| Q3 24 | — | -15.3% | ||
| Q2 24 | -4.2% | 1.3% | ||
| Q1 24 | -77.3% | -4.0% |
资本支出强度APLSKGS
| Q4 25 | 0.1% | 15.9% | ||
| Q3 25 | 0.0% | 31.7% | ||
| Q2 25 | 0.0% | 25.6% | ||
| Q1 25 | 0.0% | 23.5% | ||
| Q4 24 | 0.0% | 23.7% | ||
| Q3 24 | 0.0% | 26.7% | ||
| Q2 24 | 0.0% | 37.8% | ||
| Q1 24 | 0.2% | 27.9% |
现金转化率APLSKGS
| Q4 25 | — | 7.91× | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | 4.49× | ||
| Q1 25 | — | 3.76× | ||
| Q4 24 | — | 6.21× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 19.44× | ||
| Q1 24 | — | 1.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
KGS
| Other Services | $126.8M | 38% |
| Other | $112.2M | 34% |
| Transferred At Point In Time | $93.8M | 28% |
